Human T-cell lymphotrophic virus type-1 and organ donors [2]

Transplantation

Volumn 76, Issue 4, 2003, Pages 745-746

  Kauffman, H Myron ^a   Taranto, Sarah E ^a  

^a UNITED NETWORK FOR ORGAN SHARING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

BLOOD TRANSFUSION; CADAVER DONOR; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LETTER; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; SCREENING TEST; SPINAL CORD DISEASE; UNITED KINGDOM; VIRUS TRANSMISSION;

CADAVER; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PARAPARESIS, TROPICAL SPASTIC; TISSUE DONORS;

EID: 0042837970     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000071847.36786.C1     Document Type: Letter

References (5)

1. Toro C, Rodes B, Poveda E, et al. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of a human T-cell lymphotrophic virus type I from a single donor. Transplantation 2003; 75: 102-104.
2. Osman HK. Human T-cell lymphotrophic virus type 1: is it time to screen organ donors and recipients? Transplantation 2003; 75: 1-2.
3. Siegel RS, Gartenhaus RB, Kuzel TM. Human T-cell lymphotrophic-I-associated leukemia/lymphoma. Curr Treat Options Oncol 2001; 2: 291-300.
4. Nakatsuji Y, Sugai F, Watanabe S, et al. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci 2000; 177: 154-156.
5. Andersson S, Thorstensson R, Ramirez KG, et al. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotrophic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 1999; 39: 845-851.